LAENNEC® (Human Placental Extract Injection)
Liver Cirrhosis / Regenerative Therapy
Approved (Japan/Asia)Commercial; EU expansion 2026
Key Facts
Indication
Liver Cirrhosis / Regenerative Therapy
Phase
Approved (Japan/Asia)
Status
Commercial; EU expansion 2026
Company
About Japan Bio Product
A global leader in placenta-based regenerative medicine, developing and commercializing human placental extract products for therapeutic and wellness applications.
View full company profile